Myocardial Infarction and All-Cause Mortality Following Percutaneous Coronary Intervention Versus Conservative

Marc Meller Søndergaard1, Sanna Gunnarstein1, Martin Kirk Christensen1

  • 1Department of Cardiology, Aalborg University Hospital, Aalborg, Denmark.

Insights

Percutaneous coronary intervention for chronic coronary total occlusions (CTO-PCI) showed similar myocardial infarction risk but lower all-cause mortality compared to conservative treatment. These findings support CTO-PCI as a viable treatment option.

Area of Science:

  • Cardiovascular Medicine
  • Interventional Cardiology
  • Clinical Outcomes Research

Background:

  • Chronic coronary total occlusions (CTO) present significant treatment challenges.
  • Existing randomized trials and observational studies comparing conservative treatment with percutaneous coronary intervention (PCI) for CTO are underpowered.

Purpose of the Study:

  • To evaluate the long-term risks of myocardial infarction (MI) and all-cause mortality in patients with CTO lesions.
  • To compare outcomes between patients treated with CTO percutaneous coronary intervention (CTO-PCI) and those receiving conservative management.

Main Methods:

  • Utilized data from the West Denmark Heart Registry, identifying 7675 patients with chronic coronary syndrome and 100% occluded vessels.
  • Stratified patients into CTO-PCI (within 90 days) and conservative treatment groups.
  • Calculated 5-year risks of MI and all-cause mortality using cause-specific Cox-models and g-formula, adjusting for clinical factors and subgroup analyses.

Main Results:

  • No significant difference in 5-year MI risk was observed between CTO-PCI (13.1%) and conservative treatment (13.4%).
  • CTO-PCI demonstrated a significantly lower 5-year all-cause mortality rate (14.4%) compared to conservative treatment (18.9%).
  • Subgroup analyses revealed consistent findings, though CTO-PCI patients with prior cardiac surgery showed a higher MI risk.

Conclusions:

  • CTO-PCI is associated with a comparable 5-year risk of myocardial infarction versus conservative management.
  • Patients undergoing CTO-PCI experienced significantly lower all-cause mortality over five years compared to those treated conservatively.
Abstract

Related Concept Videos

Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...